Literature DB >> 7726494

Effect of zidovudine on transplacental pharmacokinetics of ddI in the pigtailed macaque (Macaca nemestrina).

C M Pereira1, C Nosbisch, W L Baughman, J D Unadkat.   

Abstract

Since zidovudine and ddI may be used in combination in the future to treat pregnant women who are human immunodeficiency virus positive, we conducted a study to determine whether zidovudine affects the transfer of ddI across the placenta. Zidovudine and ddI were infused simultaneously to three near-term pregnant macaques (Macaca nemestrina) at 156 +/- 1.5 days of gestation. Samples of maternal and fetal blood and amniotic fluid were drawn at intervals for 30 h. The steady-state dideoxyinosine concentrations in the plasma of the dam (Cssd), the fetus (Cssf), and the amniotic fluid (Cssa) and the ratios Cssf/Cssd and Cssa/Cssf were found to be not significantly different from the values previously determined after the administration of ddI alone during the same pregnancy. We conclude that concurrent zidovudine administration does not affect the transfer of ddI across the placenta in near-term Macaca nemestrina.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726494      PMCID: PMC162539          DOI: 10.1128/AAC.39.2.343

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection.

Authors:  N R Hartman; R Yarchoan; J M Pluda; R V Thomas; K S Marczyk; S Broder; D G Johns
Journal:  Clin Pharmacol Ther       Date:  1990-05       Impact factor: 6.875

2.  Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer.

Authors:  A Lopez-Anaya; J D Unadkat; L A Schumann; A L Smith
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

3.  Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity.

Authors:  G Ahluwalia; D A Cooney; H Mitsuya; A Fridland; K P Flora; Z Hao; M Dalal; S Broder; D G Johns
Journal:  Biochem Pharmacol       Date:  1987-11-15       Impact factor: 5.858

4.  Transfer of zidovudine (AZT) by human placenta.

Authors:  L Liebes; S Mendoza; D Wilson; J Dancis
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

5.  Azidothymidine (zidovudine) transport by the human placenta.

Authors:  S Schenker; R F Johnson; T S King; R S Schenken; G I Henderson
Journal:  Am J Med Sci       Date:  1990-01       Impact factor: 2.378

6.  Efflux of zidovudine and 2',3'-dideoxyinosine out of the cerebrospinal fluid when administered alone and in combination to Macaca nemestrina.

Authors:  T Tuntland; R J Ravasco; S al-Habet; J D Unadkat
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

7.  3'-azido-3'-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion.

Authors:  T P Zimmerman; W B Mahony; K L Prus
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

8.  Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases.

Authors:  R W Klecker; J M Collins; R Yarchoan; R Thomas; J F Jenkins; S Broder; C E Myers
Journal:  Clin Pharmacol Ther       Date:  1987-04       Impact factor: 6.875

9.  3'-Azido-2',3'-dideoxyuridine (AzddU): comparative pharmacokinetics with 3'-azido-3'-deoxythymidine (AZT) in monkeys.

Authors:  F D Boudinot; R F Schinazi; J M Gallo; H M McClure; D C Anderson; K J Doshi; P C Kambhampathi; C K Chu
Journal:  AIDS Res Hum Retroviruses       Date:  1990-02       Impact factor: 2.205

10.  Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection.

Authors:  A C Collier; R W Coombs; M A Fischl; P R Skolnik; D Northfelt; P Boutin; C J Hooper; L D Kaplan; P A Volberding; L G Davis; D R Henrard; S Weller; L Corey
Journal:  Ann Intern Med       Date:  1993-10-15       Impact factor: 25.391

View more
  3 in total

Review 1.  Antiretroviral therapy in pregnancy: a focus on safety.

Authors:  G P Taylor; N Low-Beer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Zidovudine does not affect transplacental transfer or systemic clearance of stavudine (2',3'-didehydro-3'-deoxythymidine) in the pigtailed macaque (Macaca nemestrina).

Authors:  A Odinecs; C Nosbisch; J D Unadkat
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

Review 3.  Antiretroviral bioanalysis methods of tissues and body biofluids.

Authors:  Robin DiFrancesco; Getrude Maduke; Rutva Patel; Charlene R Taylor; Gene D Morse
Journal:  Bioanalysis       Date:  2013-02       Impact factor: 2.681

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.